Northern Trust
ABCL icon

Northern Trust’s AbCellera Biologics ABCL Stock Holding History

Northern Trust’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Buy
298,615
+93,996
+46% +$459K ﹤0.01% 3040
2026
Q1 		$714K Sell
204,619
-3,453
-2% -$12.4K ﹤0.01% 3475
2025
Q4 		$712K Sell
208,072
-9,956
-5% -$44.4K ﹤0.01% 3527
2025
Q3 		$1.1M Buy
218,028
+142,246
+188% +$627K ﹤0.01% 3364
2025
Q2 		$260K Buy
75,782
+714
+1% +$1.78K ﹤0.01% 3849
2025
Q1 		$167K Sell
75,068
-6,553
-8% -$18.8K ﹤0.01% 3991
2024
Q4 		$239K Buy
81,621
+42,174
+107% +$117K ﹤0.01% 3923
2024
Q3 		$103K Sell
39,447
-935
-2% -$2.59K ﹤0.01% 4049
2024
Q2 		$120K Sell
40,382
-7,309
-15% -$27.7K ﹤0.01% 4010
2024
Q1 		$216K Sell
47,691
-8,786
-16% -$44.8K ﹤0.01% 3867
2023
Q4 		$322K Buy
+56,477
New +$262K ﹤0.01% 3703
2023
Q3 		– Sell
-100,268
Closed -$648K – 4461
2023
Q2 		$648K Sell
100,268
-1,585,189
-94% -$10.8M ﹤0.01% 3481
2023
Q1 		$12.7M Sell
1,685,457
-55,960
-3% -$508K ﹤0.01% 1863
2022
Q4 		$17.6M Buy
1,741,417
+234,169
+16% +$2.71M ﹤0.01% 1619
2022
Q3 		$14.9M Buy
1,507,248
+87,819
+6% +$964K ﹤0.01% 1696
2022
Q2 		$15.1M Buy
+1,419,429
New +$12M ﹤0.01% 1729

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Northern Trust's ABCL Position: Q2 2026 in Review

Northern Trust increased its AbCellera Biologics (ABCL) stake by 46% in Q2 2026, buying an estimated $459K and bringing the position to 298,615 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #3040.

Northern Trust first reported a position in ABCL in Q2 2022 and has held it in 16 quarters since. The position peaked at $17.6M in Q4 2022. 151 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Northern Trust held 298,615 shares of AbCellera Biologics worth $2.34M as of Q2 2026.
  • Northern Trust bought 93,996 AbCellera Biologics shares in Q2 2026, an estimated $459K.
  • AbCellera Biologics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3040 holding.
  • Northern Trust first reported a position in AbCellera Biologics in Q2 2022 and has held it in 16 quarters since.
  • Northern Trust's AbCellera Biologics position peaked at $17.6M in Q4 2022.
  • 151 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.